Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06387290 · ClinicalTrials.gov registry record · Phase 3

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

A Phase 3 study of Pain and Chronic Pain, sponsored by University of Utah.

Recruiting
Registry status
Phase 3
Development phase
300
Enrollment target
3
Study locations

NCT06387290: Recruiting Phase 3 study of Pain and Chronic Pain, sponsored by University of Utah.

NCT06387290 is a Phase 3 study of Pain and Chronic Pain that is actively recruiting participants, run by University of Utah. The registered enrollment target is 300 participants, roughly in line with the 303-participant average among 374 other Pain trials with a reported enrollment target. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06387290, a Phase 3 study of Pain and Chronic Pain, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
Phase 3
Development phase
300 participants
Enrollment target
3
Study locations

Study Summary

The primary aim of this implementation-effectiveness trial is to examine the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care as interventions to reduce chronic pain, improve quality of life, and reduce opioid-related harms among chronic pain patients on long-term opioid therapy.

Primary Outcome

Opioid misuse as evidenced by triangulated aggregate of self-reported Current Opioid Misuse Measure and/or interview via Addiction Behaviors Checklist and/or urine screen

Interventions

  • BEHAVIORAL Mindfulness Oriented Recovery Enhancement
  • BEHAVIORAL Patient-Centered Chronic Pain Management Visits

Study Locations (3)

California

  • UCSD Health - La Jolla

New Jersey

  • Rutgers University Primary Care Clinics - New Brunswick

Utah

  • University of Utah Primary Care Clinics - Salt Lake City

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-02-25
Est. Completion 2028-05-01
Phase Phase 3
University of Utah

818 total trials

What NCT06387290 shows while recruiting

NCT06387290 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 303-participant average among 374 other Pain trials with a reported enrollment target.

The record links to 9 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Oriented Recovery Enhancement is the first listed.

NCT06387290 reports a single indexed study location in California, New Jersey, Utah.

Frequently Asked Questions

What is clinical trial NCT06387290 about?

NCT06387290 is a clinical study titled "Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits". The primary aim of this implementation-effectiveness trial is to examine the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care as interventions to reduce chronic pain, improve quality of life, and reduce opioid-relat...

What is the current status of trial NCT06387290?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2025-02-25. Estimated completion is 2028-05-01.

What conditions does trial NCT06387290 study?

This clinical trial studies the following conditions: Pain, Chronic Pain, Substance-Related Disorders, Opioid-Related Disorders, Mental Disorders.

What interventions are being tested in trial NCT06387290?

The interventions under investigation include: Mindfulness Oriented Recovery Enhancement (BEHAVIORAL), Patient-Centered Chronic Pain Management Visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT06387290?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06387290 being conducted?

This trial has 3 study locations across California, New Jersey, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06387290's enrollment target sits among peer trials

300 57th of 374 higher than 315 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06387290, the US trial registry maintained by the National Library of Medicine. NCT06387290 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.